(NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases, today reported financial results for the ...
Recent Highlights Presented encouraging interim data from Cohort 1 patients in upliFT-D trial of PBFT02 for FTD-GRN at the ISFTD2024 and CTAD conferences: The company presented updated safety and ...
George, on the other hand, was great. He scored a game-best 29 points on 10-19 shooting from the field and led his team with 10 rebounds. Embiid’s goal is to help his new star teammate have ...
Recent and Upcoming Milestones Oral Small Molecule ... Third Quarter 2024 Financial Highlights Cash Position: Cash, cash equivalents and short-term investments totaled $915.3 million on September ...
In July, George R.R. Martin told fans he would soon share his thoughts on “everything that’s gone wrong” with House of the Dragon. That tantalizing tease suggested he was ready to spill a ...
"We believe the recent accelerating trend in new prescription demand reinforces the magnitude of the longer-term opportunity. In addition, we believe that our experience in the initial phases of ...
Third Quarter 2024 and Recent Highlights New Prescriptions (NRx) The four-week moving average of weekly NRx ranged between approximately 1,760 to 1,960 for the weeks ended June 28, 2024 through ...
Bubby Michael 243-633, Jeremy Crist 632, Tom Volpe 631, John Williams Jr. 630, Bill Colburn 628, Sean Peters 238-624, Brandon Pratt 238-624, Cody Kane 622, George Wendell 225-620, Adam Fiorella ...